Literature DB >> 21679972

Progress in defining the premotor phase of Parkinson's disease.

Eduardo Tolosa1, Claustre Pont-Sunyer.   

Abstract

Several studies have suggested that a variety of non-motor symptoms (NMS) frequently antedate the development of the classical motor symptoms in Parkinson's disease (PD). Some of these premotor symptoms are well known, like REM sleep behaviour disorder, smell loss and constipation and can precede the motor symptoms by years or even decades. The appearance of these symptoms seems to correlate with the neuropathological changes occurring during Braaks stages I to III. Also studies of the nigrostriatal dopaminergic pathways with neuroimaging show that substantia nigra degeneration occurs before motor symptoms onset. Studies on the premotor phase of PD are important for our understanding of when and where does PD start and how it evolves in these initial stages. Several ongoing studies combine clinical, genetic and neuroimaging investigations to study the premotor phase in subjects at high risk for developing such as hyposmic individuals (PARS study) or nonmanifesting carriers of LRRK2 mutations (ASAP Study). The diagnosis of premotor PD remains still elusive but the information becoming available on premotor PD should guide the search for predictive biomarkers and the identification of risk or protective factors for PD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21679972     DOI: 10.1016/j.jns.2011.05.027

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

Review 1.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Authors:  Daniel A Barone; Claire Henchcliffe
Journal:  Clin Neurophysiol       Date:  2018-05-29       Impact factor: 3.708

2.  Parkinson disease: New guidelines for diagnosis of Parkinson disease.

Authors:  Maria José Martí; Eduardo Tolosa
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

3.  Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression.

Authors:  Dolores Vilas; Alex Iranzo; Claustre Pont-Sunyer; Mónica Serradell; Carles Gaig; Joan Santamaria; Eduardo Tolosa
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

4.  The prion hypothesis of Parkinson's disease.

Authors:  Yaping Chu; Jeffrey H Kordower
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

5.  Distribution of α-Synuclein Aggregation in the Peripheral Tissues.

Authors:  Yan-Yan Li; Tian-Tian Zhou; Yi Zhang; Nai-Hong Chen; Yu-He Yuan
Journal:  Neurochem Res       Date:  2022-03-28       Impact factor: 3.996

6.  Morbidities in rapid eye movement sleep behavior disorder.

Authors:  Poul Jennum; Geert Mayer; Yo-El Ju; Ron Postuma
Journal:  Sleep Med       Date:  2013-01-29       Impact factor: 3.492

Review 7.  How Wearable Sensors Can Support Parkinson's Disease Diagnosis and Treatment: A Systematic Review.

Authors:  Erika Rovini; Carlo Maremmani; Filippo Cavallo
Journal:  Front Neurosci       Date:  2017-10-06       Impact factor: 4.677

8.  Can Qigong improve non-motor symptoms in people with Parkinson's disease - A pilot randomized controlled trial?

Authors:  Sanghee Moon; Caio V M Sarmento; Michael Steinbacher; Irina V Smirnova; Yvonne Colgrove; Sue-Min Lai; Kelly E Lyons; Wen Liu
Journal:  Complement Ther Clin Pract       Date:  2020-04-02       Impact factor: 2.446

9.  Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers.

Authors:  Claustre Pont-Sunyer; Alex Iranzo; Carles Gaig; Ana Fernández-Arcos; Dolores Vilas; Francesc Valldeoriola; Yaroslau Compta; Ruben Fernández-Santiago; Manel Fernández; Angels Bayés; Matilde Calopa; Pilar Casquero; Oriol de Fàbregues; Serge Jaumà; Victor Puente; Manel Salamero; Maria José Martí; Joan Santamaría; Eduard Tolosa
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

10.  No apparent transmission of transgenic α-synuclein into nigrostriatal dopaminergic neurons in multiple mouse models.

Authors:  Namratha Sastry; Wang Zheng; Guoxiang Liu; Helen Wang; Xi Chen; Michael Cai; Parth Contractor; Carmelo Sgobio; Lixin Sun; Chengsong Xie; Huaibin Cai
Journal:  Transl Neurodegener       Date:  2015-12-03       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.